Delivery Order SPE2DB20D2104-SPE2DB24FU49G
Award Date
6/3/24
Potential Completion Date
6/4/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Trokendi XR 100 mg capsules. The contract, valued at $1,851.60, is a Delivery Order that runs through October 31, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026, which serves as a primary...
This federal contract award, with the ID SPE2DB22D1106|SPE2DB25FDVP5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,622.38 Firm Fixed Price delivery order is for the pharmaceutical product Trokendi XR 50 mg capsules, and has an ultimate completion date of January 24, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,456.54 firm fixed-price delivery order contract is for the supply of Trokendi XR 50 mg capsules. The contract has an ultimate completion date of February 10, 2025 and was awarded on February 7, 2025. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,090.69, is a firm fixed price delivery order for the pharmaceutical product Trokendi XR 200 mg capsules. The award has an ultimate completion date of March 25, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,053.04, is a delivery order for the supply of Trokendi XR 100 mg capsules. The contract has a period of performance through February 24, 2025 and utilizes a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,969.00 fixed-price delivery order is for the supply of Trokendi XR 100 mg capsules to support federal healthcare programs. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order for the pharmaceutical product Trokendi XR 50 mg capsules awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,208.55 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on January 27, 2025 and has an ultimate completion date of January 28, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime...
This federal contract award, with the ID SPE2DB22D3004|SPE2DB25FNZ65, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,051.38, is for the delivery of Trokendi XR 50 mg capsules. It is a firm-fixed-price delivery order contract with an ultimate completion date of January 6, 2025. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, with ID SPE2DB20D3103|SPE2DB21FP7A9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,500.49 firm fixed-price delivery order is for the supply of the prescription medication Trokendi XR 100 mg capsules. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,522.52 Firm Fixed Price contract is for the delivery of Trokendi XR 100 mg capsules and has a completion date of June 25, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December...